Please check your internet connection and try again.
## Diadzein + Genistein + Palmitoylethanolamide
### Overview
This combination product contains genistein (an isoflavone), daidzein (another isoflavone), and palmitoylethanolamide (PEA). Genistein and daidzein are phytoestrogens. PEA is an endogenous fatty acid amide.
### Primary Indications
This combination is primarily marketed as a dietary supplement for various purposes including pain management and inflammatory conditions. Its use as a pharmaceutical agent for specific indications is not established in major clinical guidelines.
### Adult Dosing
Dosage varies widely depending on the specific product formulation and intended use. Typical daily doses for the individual components in supplements range from:
* **Genistein:** 10-100 mg
* **Daidzein:** 10-60 mg
* **Palmitoylethanolamide (PEA):** 300-1200 mg
Specific dosing for this combination product should follow manufacturer recommendations or be determined by a healthcare provider.
### Pediatric Dosing
There is insufficient data to establish pediatric dosing for this combination product. Its use in pediatric populations is not recommended without explicit guidance from a qualified healthcare professional.
### Dose Adjustments
No specific dose adjustments for renal or hepatic impairment are established for this combination product due to its status as a dietary supplement.
### Contraindications
* Hypersensitivity to any component of the product.
* Individuals with hormone-sensitive cancers should exercise caution and consult their healthcare provider due to the phytoestrogenic nature of genistein and daidzein.
### Adverse Effects
Adverse effects are generally rare and mild, but may include gastrointestinal upset (nausea, diarrhea), headache, or allergic reactions. Due to the phytoestrogenic effects, there is a theoretical risk of hormonal disruption, especially with prolonged high-dose use.
### Key Drug Interactions
* **Hormonal Therapies:** Potential for additive or antagonistic effects with hormone replacement therapy or oral contraceptives.
* **Tamoxifen:** Genistein and daidzein may interact with tamoxifen, potentially affecting its efficacy.
* **Thyroid Medications:** Isoflavones may affect thyroid function; monitor patients on thyroid medication.
### Monitoring
Monitoring is generally not standardized as this is a supplement. Patients should report any new or worsening symptoms to their healthcare provider.
### Clinical Pearls
* The efficacy and safety of this combination product are not well-established through rigorous clinical trials for specific medical conditions.
* Patients should be advised that dietary supplements are not regulated by the FDA in the same way as prescription drugs.
* Advise patients to discuss the use of this supplement with their healthcare provider, especially if they have pre-existing medical conditions or are taking other medications.
***
*This information is intended for healthcare professionals and does not substitute for comprehensive drug information resources. Always consult the most current prescribing information and relevant clinical guidelines before making therapeutic decisions.*
